- Home
- ENSC vs SOPA Comparison
ENSC vs SOPA Comparison
Compare ENSC & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- SOPA
- Stock Information
- Founded
- ENSC 2003
- SOPA 2018
- Country
- ENSC United States
- SOPA Singapore
- Employees
- ENSC N/A
- SOPA N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- SOPA EDP Services
- Sector
- ENSC Health Care
- SOPA Technology
- Exchange
- ENSC Nasdaq
- SOPA Nasdaq
- Market Cap
- ENSC 3.4M
- SOPA 3.8M
- IPO Year
- ENSC N/A
- SOPA 2021
- Fundamental
- Price
- ENSC $2.34
- SOPA $1.16
- Analyst Decision
- ENSC
- SOPA Strong Buy
- Analyst Count
- ENSC 0
- SOPA 1
- Target Price
- ENSC N/A
- SOPA $14.00
- AVG Volume (30 Days)
- ENSC 5.0M
- SOPA 1.2M
- Earning Date
- ENSC 05-13-2025
- SOPA 05-23-2025
- Dividend Yield
- ENSC N/A
- SOPA N/A
- EPS Growth
- ENSC N/A
- SOPA N/A
- EPS
- ENSC N/A
- SOPA N/A
- Revenue
- ENSC $6,224,081.00
- SOPA $7,105,530.00
- Revenue This Year
- ENSC N/A
- SOPA $26.32
- Revenue Next Year
- ENSC N/A
- SOPA N/A
- P/E Ratio
- ENSC N/A
- SOPA N/A
- Revenue Growth
- ENSC 256.35
- SOPA N/A
- 52 Week Low
- ENSC $1.62
- SOPA $0.65
- 52 Week High
- ENSC $14.67
- SOPA $6.75
- Technical
- Relative Strength Index (RSI)
- ENSC 46.40
- SOPA 55.82
- Support Level
- ENSC $1.99
- SOPA $1.01
- Resistance Level
- ENSC $2.40
- SOPA $1.33
- Average True Range (ATR)
- ENSC 0.26
- SOPA 0.15
- MACD
- ENSC 0.02
- SOPA 0.02
- Stochastic Oscillator
- ENSC 28.00
- SOPA 40.45
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.